Loading the company…
Loading the company…
In the last ten years FDA made 0 decisions for MiMedx (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family. The latest was on 2011-06-14.
| Family | Decisions on record |
|---|---|
| Hernia repair | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2011-06-14 | 510(k) | K100313 | HYDROFIX SURGICAL SHEET |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to MiMedx.
In 2025, MiMedx reported engagement with 213 surgeons and other clinicians in the states MedaRep covers, worth $337K in consulting, speaking, meals and travel for its device products, the most in Texas ($131K to 105). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Texas ($131K, 105 engaged), California ($37K, 34 engaged), Colorado ($29K, 2 engaged), Michigan ($23K, 1 engaged), Tennessee ($22K, 24 engaged).